Fast4ward Learning
About Fast4ward Learning
Fast4ward Learning is a healthcare education company dedicated to delivering credible, evidence‑based medical education that drives improvements in patient care. Known for creating engaging, fair, and balanced programs with a national reach across more than 100 sites, Fast4ward Learning focuses on fostering meaningful peer‑to‑peer learning experiences that help clinicians deepen their clinical knowledge and stay current in their fields.
In addition to its educational programs, Fast4ward Learning captures and synthesizes provider perspectives into structured Educational Outcomes and Strategic Insights reports, which highlight practice patterns, care gaps, and opportunities for improvement. This dual approach ensures that their programming not only educates but also generates actionable insights that can inform strategy, guide evidence generation, and ultimately support better patient outcomes.
About Challenging Cases in Cancer: TP53 Mutant Myeloid Neoplasms
This accredited activity provides hematology and oncology professionals with focused, practical education on the complex management of TP53-mutated myeloid neoplasms across the MDS and AML continuum.
Through expert-led instruction, integrated knowledge checks, and real-world patient cases, learners explore how to interpret TP53 mutation status alongside next-generation sequencing, cytogenetic findings, variant allele frequency, and allelic state. The activity examines contemporary prognostic frameworks and the biologic relationship between TP53-mutated MDS and AML, helping clinicians move beyond blast count alone when evaluating disease risk and planning care.
Learners also review evolving evidence surrounding available treatment strategies, including hypomethylating agents, venetoclax-based and intensive chemotherapy regimens, and the role and timing of allogeneic stem cell transplantation.
Designed as a flexible, on-demand learning experience, this activity equips clinicians to translate rapidly changing molecular and clinical evidence into more confident, individualized treatment decisions for patients facing these high-risk myeloid malignancies.
About IDH1-Mutant Myeloid Neoplasms Continuum: Clonal Evolution Across CCUS, MDS, and AML
This accredited activity explores the evolving role of IDH1 mutations across the continuum of clonal cytopenia of undetermined significance (CCUS), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). Led by Rami Komrokji, MD, the program combines expert instruction with case-based discussion to help healthcare professionals translate rapidly advancing molecular science into informed clinical decision-making.
Learners examine contemporary WHO and ICC classification frameworks, molecular risk stratification, and the role of next-generation sequencing in diagnosis, prognosis, and disease monitoring. The activity also reviews the clinical and prognostic significance of IDH1 mutations, emerging evidence for targeted therapies, and considerations for patient selection, treatment sequencing, and adverse-event management.
By following IDH1-mutated disease across multiple stages of the myeloid neoplasm continuum, this activity offers a practical, integrated perspective on how molecular findings can shape earlier recognition, risk assessment, treatment planning, and referral—equipping clinicians to apply evolving evidence to individualized, evidence-based patient care.
How Pinnacle Supported Fast4ward Learning Through Joint Providership
Through joint providership, Learn at Pinnacle partnered with Fast4ward Learning to deliver fully accredited continuing education designed to advance clinical knowledge, improve patient care, and support meaningful peer-to-peer learning across healthcare providers. Pinnacle managed the complete accreditation process—ensuring CME/CE compliance, overseeing all required documentation, and validating credit eligibility for participating clinicians—allowing the Fast4ward team to focus fully on delivering high-quality, evidence-based education.
By handling the regulatory and administrative requirements, Pinnacle enabled Fast4ward Learning to dedicate its efforts to creating engaging programs and translating provider perspectives into actionable insights for clinical practice. This collaboration reflects Pinnacle’s commitment to making accreditation seamless and accessible while upholding the highest standards of educational integrity. Together, they created a fully accredited learning experience that equips healthcare professionals with the knowledge, practical tools, and confidence to improve patient outcomes and advance clinical excellence.
